CN103768431A - Composition for treating intense toxic heat type lupus erythematosus - Google Patents
Composition for treating intense toxic heat type lupus erythematosus Download PDFInfo
- Publication number
- CN103768431A CN103768431A CN201410005385.0A CN201410005385A CN103768431A CN 103768431 A CN103768431 A CN 103768431A CN 201410005385 A CN201410005385 A CN 201410005385A CN 103768431 A CN103768431 A CN 103768431A
- Authority
- CN
- China
- Prior art keywords
- parts
- lupus erythematosus
- composition
- heat type
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a composition for treating intense toxic heat type lupus erythematosus, and relates to the field of traditional Chinese medicines. The composition comprises the following components in parts by weight: 8-12 parts of scorpion, 8-12 parts of raw rehmannia, 8-12 parts of red peony root, 8-12 parts of moutan bark, 8-12 parts of radices trichosanthis, 12-18 parts of honeysuckle, 12-18 parts of fructus forsythiae, 12-18 parts of radix polygonati officinalis, 12-18 parts of dendrobe, 15-25 parts of lalang grass rhizome, 15-25 parts of radix scrophulariae, and 15-25 parts of radix asparagi and dwarf lilyturf root. The composition for treating intense toxic heat type lupus erythematosus is reasonable in compatibility, has a remarkable effect for treating systemic lupus erythematosus, does not have toxic or side effects, and has cure rate over 80 percent.
Description
Technical field:
The present invention relates to tcm field, relate in particular to a kind of compositions for the treatment of scorchingly hot flourishing type lupus erythematosus.
Background technology:
Systemic lupus erythematosus (sle) (systemic lupus erythematosus, SLE) is a kind of autoimmune disease that involves multisystem, many organs and have multiple autoantibody to occur.Owing to having a large amount of pathogenic autoantibodys and immune complex to cause tissue injury in body.Can there is clinically the performance of each system and visceral organ injury, as skin, joint, serous coat, heart, kidney, central nervous system, blood system etc.This disease worldwide occurs, and prevalence is 4,/10 ten thousand～25,/10 ten thousand, and Asia and Black people's prevalence are higher, and the prevalence of China is 70,/10 ten thousand～75,/10 ten thousand.Women falls ill obviously more than male, is about 10: 1, and the women of child-bearing age are onset peak, and old man and child also can be ill.
Primary disease belongs to YIN YANG toxin syndrome, the YANG toxin syndrome of Chinese medicine and sends out the disease categories such as speckle, butterfly spot, solar dermatitis, chronic erythematosus, seborrheic dermatitis.The curative effect of medication for the treatment of lupus erythematosus is not good at present, and side effect is stronger, and cure rate is not high.
Summary of the invention:
The object of the present invention is to provide a kind of compositions for the treatment of scorchingly hot flourishing type lupus erythematosus, to solve the problems of the technologies described above.
Technical problem to be solved by this invention realizes by the following technical solutions:
A compositions for the treatment of scorchingly hot flourishing type lupus erythematosus, is characterized in that, comprises following component and group component:
The preferred group component of each component is:
Above pharmaceutical composition in use, according to the dialectical plus-minus medicine of the state of an illness: hyperpyrexia adds Cornu Bubali powder and takes after mixing it with water, lasting underground heat adds Cortex Lycii, Radix Stellariae, the Rhizoma Anemarrhenae, cardiac insufficiency adds Radix Ginseng, and anasarca adds Spora Lygodii, celestial being's head, and lumbago adds the Cortex Eucommiae, menoxenia adds Herba Leonuri leaf, Herba Lycopi, erythema obviously adds Flos Celosiae Cristatae, Flos Rosae Rugosae, Flos Campsis, and mental symptom adds Fel Serpentis, Pericarpium Citri Reticulatae end, and urine retention adds WUPI YIN.
This pharmaceutical composition adopts traditional approach decoction.
The invention has the beneficial effects as follows:
The compositions of the scorchingly hot flourishing type lupus erythematosus for the treatment of provided by the invention, compatibility is reasonable, remarkable to systemic lupus erythematosus effect, has no side effect, and cure rate can reach more than 80%.
The specific embodiment:
For technological means, creation characteristic that the present invention is realized, reach object and effect is easy to understand, below in conjunction with specific embodiment, further set forth the present invention.
Embodiment 1
Treat a compositions for scorchingly hot flourishing type lupus erythematosus, component is:
This pharmaceutical composition adopts Chinese medicine decocting method, gets its decoction liquor and takes.
Embodiment 2
Treat a compositions for scorchingly hot flourishing type lupus erythematosus, component is:
This pharmaceutical composition adopts Chinese medicine decocting method, gets its decoction liquor and takes.
Embodiment 3
Treat a compositions for scorchingly hot flourishing type lupus erythematosus, component is:
This pharmaceutical composition adopts Chinese medicine decocting method, gets its decoction liquor and takes.
More than show and described ultimate principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what in above-described embodiment and description, describe is only preference of the present invention; be not used for limiting the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.The claimed scope of the present invention is defined by appending claims and equivalent thereof.
Claims (2)
1. a compositions for the treatment of scorchingly hot flourishing type lupus erythematosus, is characterized in that, comprises following component and group component:
2. the compositions of the scorchingly hot flourishing type lupus erythematosus for the treatment of according to claim 1, is characterized in that, the preferred group component of each component is:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005385.0A CN103768431A (en) | 2014-01-03 | 2014-01-03 | Composition for treating intense toxic heat type lupus erythematosus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005385.0A CN103768431A (en) | 2014-01-03 | 2014-01-03 | Composition for treating intense toxic heat type lupus erythematosus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103768431A true CN103768431A (en) | 2014-05-07 |
Family
ID=50561491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410005385.0A Pending CN103768431A (en) | 2014-01-03 | 2014-01-03 | Composition for treating intense toxic heat type lupus erythematosus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103768431A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105031336A (en) * | 2015-07-10 | 2015-11-11 | 冉宇欣 | Medicine for treating toxic heat flourishing systemic lupus erythematosus and preparation method of medicine |
| CN105055848A (en) * | 2015-07-22 | 2015-11-18 | 黄红妹 | Traditional Chinese medicinal composition for treating lupus erythematosus |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101766791A (en) * | 2010-04-19 | 2010-07-07 | 泰一和浦（北京）中医药研究院有限公司 | Chinese herbal composite for fever treatment and preparation method thereof |
| CN101874879A (en) * | 2010-04-23 | 2010-11-03 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating osteopyrexia and preparation method thereof |
-
2014
- 2014-01-03 CN CN201410005385.0A patent/CN103768431A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101766791A (en) * | 2010-04-19 | 2010-07-07 | 泰一和浦（北京）中医药研究院有限公司 | Chinese herbal composite for fever treatment and preparation method thereof |
| CN101874879A (en) * | 2010-04-23 | 2010-11-03 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating osteopyrexia and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105031336A (en) * | 2015-07-10 | 2015-11-11 | 冉宇欣 | Medicine for treating toxic heat flourishing systemic lupus erythematosus and preparation method of medicine |
| CN105055848A (en) * | 2015-07-22 | 2015-11-18 | 黄红妹 | Traditional Chinese medicinal composition for treating lupus erythematosus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101134085A (en) | Traditional Chinese medicine for treating apoplectic hemiplegia | |
| CN103505698A (en) | Traditional Chinese medicine composition for treating malignant lymphoma | |
| CN104906368A (en) | Traditional Chinese medicine composition for treating systemic lupus erythematosus | |
| CN101152337A (en) | Traditional Chinese medicine for treating tinnitus caused by hyperactivity of liver-fire and gallbladder-fire | |
| CN101134065A (en) | Traditional Chinese medicine for treating intestinal obstruction | |
| CN103768431A (en) | Composition for treating intense toxic heat type lupus erythematosus | |
| CN101229337B (en) | Chinese traditional medicine for treating bronchitis and bronchial asthma | |
| CN101129695A (en) | Traditional Chinese medicine for treating headache due to liver depression | |
| CN103550679A (en) | Traditional Chinese medicine formula for treatment of lithangiuria | |
| CN103751557A (en) | Composition for treating toxic heat injury and yin qi type lupus erythematosus | |
| CN102309600A (en) | Traditional Chinese medicine prescription for treating acne rosacea | |
| CN103751348A (en) | Composition for treating meridian-collateral blockage type lupus erythematosus | |
| CN101130003A (en) | Traditional Chinese medicine for treating acute cholecystitis | |
| CN104940892A (en) | Chinese herbal medicine for treating diarrhea | |
| CN104998147A (en) | Traditional Chinese medicine composition for treating pulmonary tuberculosis | |
| CN103751475A (en) | Composition for treating spleen-kidney deficiency lupus erythematosus | |
| CN104127602A (en) | Traditional Chinese medicine for treating fatty liver | |
| CN103505670A (en) | Traditional Chinese medicine composition for treating primary bronchus lung cancer | |
| CN103316283A (en) | Traditional Chinese medicinal composition for treating chronic cholecystitis, and preparation method thereof | |
| CN101152410A (en) | Traditional Chinese medicine for treating alopecia | |
| CN101143194A (en) | Traditional Chinese medicine for treating interstitial pneumonia | |
| CN101138604A (en) | Traditional Chinese medicine for treating intractable cough | |
| CN108210744A (en) | It is a kind of to treat the scorchingly hot composition for injuring cloudy gas type lupus erythematosus | |
| CN106822772A (en) | A kind of Traditional chinese medicine medicament formula for treating rheumatic arthritis | |
| CN114931620A (en) | Medicine for treating waist and leg pain, headache, facial hemiparalysis and breast innominate tumor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140507 |